Member Info for Reprobus

Bydna, managed to pick up some ARB today @ 14.5p. Looking forward to see what this company can achieve!

Mel, personally i cannot see it having a negative effect on SP, but time shall tell.

And lol at that 15m share trader.
Big buyers aren't always smart money, sometimes fools come into wealth and don't know how to invest properly.

Just bagged another 2.5m @ 0.0662p, bargain!

Yesterday’s close was 9p, Pumpky.

I agree Spurs, this share has been in a downtrend since September when the Eli deal was postponed.

However, that deadline will come to a close within the next three weeks and since September, Vlad has further strengthened Hemo’s position within the negotiation.

The de-rampers have been out in force recently which is a good sign.

GLA

Dropping consistently? Hemo has been in a steady uptrend for the past week.

And if you haven’t noticed, a lot of the UK micro caps are down today.

I’m saying you should probably have more patience, as it’s a vital tool when it comes to investing in stocks and shares.

“Risk comes from not knowing what you're doing” ~ W. Buffet

Caveman, if your average is 0.017p that makes you 30% down. And if you’ve been in this share for a while you’ll know that 0.012p is now a solid base.

My average is 0.015p and I’m not sweating one bit. This is one of those shares which has had a terrible start, but could blossom into something magical in the future.


Long comfortable hold for me, GLA.

Alwaysone, why so negative?

According to last weeks RNS, we can be expecting the remaining 80% of essay results within the next 4 weeks.

IMO, 3p can be easily achieved in the near future.

News so nice you had to say it twice.

Good luck with your future investments TT.

There will be a lot of eyes looking Hemo’s way next week at the ASH Expo! Vlad’s got a busy month ahead, and I’m sure he’s more than prepared.

“Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce its participation in this year's American Society of Hematology (ASH) meeting and exposition, taking place December 5-8, 2020.

Scientists from the Company will present a poster entitled "FLT3-CD3 Bispecific Antibody Specifically Eliminates Normal Hematopoietic Progenitors and AML in Humanized Mouse Models" in this year's conference, which will be taking place virtually due to the COVID-19 pandemic. The poster will be presented within the session "Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III" on Monday, December 7, 2020.”

https://www.biospace.com/article/releases/hemogenyx-pharmaceuticals-plc-announces-presentation-at-the-american-society-of-hematology/

“The American Society of Hematology (ASH) leads the world in promoting and supporting clinical and scientific hematology research through its many innovative award programs, meetings, publications, and advocacy efforts.”

https://www.hematology.org/meetings/annual-meeting

Many of those sells are actually buys, including my 5m top up

Very true Carrib, patience is fine by me.

Looking forward to what the rest of December brings, with 80% of results yet to land!

It's a shame that there are so many people looking for short term gains, as this could have surpassed a 10% rise if it wasn't for the sellers.

Either way, still more than happy with today's results.

Very positive results, I’m pleased also!

So 20% of results now received.
Currently waiting on Baggy Green, Baggy Green North, Barns and White Tank deposits which are now expected to be received between late December 2020 and early January 2021.

This is going to be a good month!

Suzie, you’re advising people to sell their shares while also claiming to hold shares yourself.
You genuinely have zero credibility.

So let’s analyse your claim that Hemo have signed up to “death spiral” finance. According to Wiki, that term refers to badly constructed convertible finance, which Hemo’s deal with Mint is not.

If you want to see an example of genuine death spiral finance, go to the Iconic Labs board and see how they liquidated their share by 95% in order to pay off debts.

There have been countless companies who have signed up to CLN’s which have been highly successful, and if Hemo choose to draw down on their’s they’ll be added to that list of success.

Your claims are an insult to Hemo’s genius.

So we've had the doom and gloomers on, speculating on worst case scenarios and avoiding the huge near term potential.

What news do we think the final month of 2020 will have in store for us?
Off the top of my head, i think news will come in the following order:

1. Penn/Car-T Update
2. ASH Expo (creating more publicity)
3. CBR Patent
4. CDX/Eli Deal

GLA

Yes Suzi, just like Tesla's $3b CLN destroyed their SP

Hooray Suzie is back! Get us another bargain buy in price will you

Clearly you have no clue about this share. Hemo isn't a Covid share

According to Vlad £12m will be sufficient to take CDX & CAR-T into clinical trials, and push CBR into IND enabling studies.

So i think i'll take his word over yours sorry Pumpkin